BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1689602)

  • 1. Premature onset of fast axonal transport in bromophenylacetylurea neuropathy: an electrophoretic analysis of proteins exported into motor nerve.
    Oka N; Brimijoin S
    Brain Res; 1990 Feb; 509(1):107-10. PubMed ID: 1689602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Axonal transport of enzymes and labeled proteins in experimental axonopathy induced by p-bromophenylacetylurea.
    Jakobsen J; Brimijoin S
    Brain Res; 1981 Dec; 229(1):103-22. PubMed ID: 6171326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Axonal transport in the motor neurons of rats with neuropathy induced by p-bromophenylacetylurea.
    Nagata H; Brimijoin S
    Ann Neurol; 1986 May; 19(5):458-64. PubMed ID: 2424360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered spectrum of retrogradely transported axonal proteins in p-bromophenylacetylurea neuropathy.
    Oka N; Brimijoin S
    Neurochem Res; 1993 Jun; 18(6):675-80. PubMed ID: 8389990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tubulomembranous lesions in p-bromophenylacetylurea neuropathy reflect local stasis of fast axonal transport: evidence from electron microscopic autoradiography.
    Oka N; Brimijoin WS
    Mayo Clin Proc; 1992 Apr; 67(4):341-8. PubMed ID: 1372380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Slow axonal transport in experimental hypoxia and in neuropathy induced by p-bromophenylacetylurea.
    Nagata H; Brimijoin S; Low P; Schmelzer JD
    Brain Res; 1987 Oct; 422(2):319-26. PubMed ID: 2445441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurotoxicity of halogenated phenylacetylureas is linked to abnormal onset of rapid axonal transport.
    Nagata H; Brimijoin S
    Brain Res; 1986 Oct; 385(1):136-42. PubMed ID: 2429734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Slab gel analysis of rapidly transported proteins in the isolated frog nervous system.
    Barker JL; Neale JH; Bonner WM
    Brain Res; 1977 Mar; 124(1):191-6. PubMed ID: 66086
    [No Abstract]   [Full Text] [Related]  

  • 9. [Abnormalities of axonal transport as pathogenesis of axonal degeneration in peripheral neuropathy].
    Nagata H
    Rinsho Shinkeigaku; 1990 Dec; 30(12):1355-7. PubMed ID: 1966015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unimpaired energy metabolism in experimental neuropathy induced by p-bromophenylacetylurea.
    Brimijoin S; Mintz KP
    Muscle Nerve; 1984; 7(9):725-32. PubMed ID: 6100457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vacor neuropathy: ultrastructural and axonal transport studies.
    Watson DF; Griffin JW
    J Neuropathol Exp Neurol; 1987 Jan; 46(1):96-108. PubMed ID: 2432196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axonal transport in neuropathy.
    Jakobsen J; Brimijoin S; Sidenius P
    Muscle Nerve; 1983 Feb; 6(2):164-6. PubMed ID: 6190080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conditioning nerve crush accelerates cytoskeletal protein transport in sprouts that form after a subsequent crush.
    McQuarrie IG; Jacob JM
    J Comp Neurol; 1991 Mar; 305(1):139-47. PubMed ID: 1709646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and electrophysiological characteristics of the experimental neuropathy caused by p-bromophenylacetylurea.
    Jakobsen J; Lambert EH; Carlson G; Brimijoin S
    Exp Neurol; 1982 Jan; 75(1):158-72. PubMed ID: 6174359
    [No Abstract]   [Full Text] [Related]  

  • 15. Axonal transport of neurofilament is accelerated in peripheral nerve during 2,5-hexanedione intoxication.
    Monaco S; Jacob J; Jenich H; Patton A; Autilio-Gambetti L; Gambetti P
    Brain Res; 1989 Jul; 491(2):328-34. PubMed ID: 2475210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of fast and slow transported proteins in dorsal root and sciatic nerve of cat.
    Sabri MI; Ochs S
    J Neurobiol; 1973; 4(2):145-65. PubMed ID: 4121429
    [No Abstract]   [Full Text] [Related]  

  • 17. Axoplasmic transport with velocities induced by pargyline.
    Watson DF; Donoso JA; O'Neill RE; Samson FE
    J Neurosci Res; 1980; 5(6):563-78. PubMed ID: 6162964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotoxic potentiation is related to a metabolic interaction between p-bromophenylacetylurea and phenylmethanesulfonyl fluoride.
    Xu J; Lister T; Purcell WM; Ray DE
    Toxicol Appl Pharmacol; 1999 Jun; 157(3):222-6. PubMed ID: 10373406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fast axonal transport in central nervous system and peripheral nervous system axons following axotomy.
    Redshaw JD; Bisby MA
    J Neurobiol; 1984 Mar; 15(2):109-17. PubMed ID: 6201591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age difference in the metabolism of p-bromophenylacetylurea in the rat: an implication for age-related susceptibility to its neurotoxicity.
    Xu J; Purcell WM; Ray DE
    Neurotoxicology; 2000 Jun; 21(3):289-93. PubMed ID: 10894117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.